Sign up
Quantellect · Congress · Trade Detail
NYSE: NVSNovartis AG ADR
RepublicanSenate

Alan Armstrong bought Novartis AG ADR (NYSE: NVS)

Alan Armstrong (R-OK), a U.S. Senator, has disclosed 2 trades in Novartis AG ADR (NVS) since 2026, all purchases, worth an estimated $41K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Alan Armstrong bought $15,001 - $50,000 of Novartis AG ADR (NYSE: NVS) on March 30, 2026. Since that trade, NVS is up +5.63% against the S&P 500 up +15.43%, an outperformance of -9.79%.

Across these filings, Alan Armstrong has been a net buyer of NVS. The most recent disclosed NVS transaction shown was dated March 31, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

NVS trades
2
Disclosed Vol
$41K
Buys
2
100%
Sells
0
0%
Buy / Sell
All buys
ratio
First → Last
2026

Alan Armstrong's NVS trades vs the price

NVS is up +5.63% since Alan Armstrong bought on March 30, 2026, versus +15.43% for the S&P 500.

Performance since this trade

Price change since trade
+5.63%
S&P 500 change since trade
+15.43%
Outperformance vs S&P 500
-9.79%

All Alan Armstrong NVS trades

TradedTypeSizeReturnEst. profit
March 31, 2026BUY$152.75+3.98%+$318
March 30, 2026BUY$150.36+5.63%+$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Alan Armstrong & NVS trading FAQ

Is it legal for Alan Armstrong to trade Novartis AG ADR (NVS) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Alan Armstrong buy NVS?

Alan Armstrong disclosed a purchase of $15,001 - $50,000 of Novartis AG ADR (NVS) on March 30, 2026, according to public STOCK Act filings.

How has NVS performed since Alan Armstrong's trade?

Since Alan Armstrong bought NVS on March 30, 2026, the stock is up +5.63%, versus +15.43% for the S&P 500 over the same period, an outperformance of -9.79%.

How many times has Alan Armstrong traded NVS?

Alan Armstrong has disclosed 2 NVS trades since 2026. Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional NVS trades?

Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.

Alan Armstrong's NVS tradesAll congressional filings for Novartis AG ADRAlan Armstrong's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.